Drug Trial Radar · NCT07015905
REGN7508 Versus Apixaban and Enoxaparin for Thromboprophylaxis After Total Knee Arthroplasty in Adults
Last checked: Nov 19, 2026Latest source record: Nov 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
2,000
Planned (sponsor's estimate)
Start
Jun 25, 2025
Primary completion
Feb 20, 2027
Study completion May 12, 2027
Sponsor
- Lead sponsor
- Regeneron PharmaceuticalsRegeneron (REGN)
- Sponsor type
- Industry
- First posted
- Jun 11, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is researching an experimental drug called REGN7508 (called "study drug"). The study is focused on adults undergoing elective, unilateral (one side) total knee replacement surgery. The aim of the study is to see how effective the study drug is at preventing Venous Thromboembolism (VTE) and other related diseases after total knee replacement surgery. The study is looking at several other research questions, including: * What side effects may happen from taking the study drug * How much study drug is in the blood at different times * Whether the body makes antibodies against the study drug (which could make the study drug less effective or could lead to side effects)
Conditions
- Venous Thromboembolism (VTE)
Interventions
REGN7508Drug
Administered per the protocol
ApixabanDrug
Administered per the protocol
EnoxaparinDrug
Administered per the protocol
PlaceboDrug
Administered per the protocol
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of the composite endpoint of asymptomatic or symptomatic Venous Thromboembolism (VTE) [including VTE-related death]Time frame: Through day 12 visit, approximately 14 days
Locations
47 sites in 8 countries. Site status is shown where the registry gives one.
Shoals Medical Trials, Inc.
Sheffield, Alabama · Recruiting
CARI Clinical Trials
Riverside, California · Recruiting
Denver Metro Orthopedics, P.C. Englewood Location
Englewood, Colorado · Recruiting
Delray Physician Care Center
Delray Beach, Florida · Recruiting
Bioresearch Partner
Miami, Florida · Recruiting
Sacred Heart Health System Inc
Pensacola, Florida · Recruiting
Gulfcoast Research Institute
Sarasota, Florida · Recruiting
Phoenix Clinical Research
Tamarac, Florida · Recruiting
Sinai Hospital of Baltimore, Inc.
Baltimore, Maryland · Recruiting
Brigham and Women's Hospital
Boston, Massachusetts · Recruiting
Curalta Clinical Trials
Westwood, New Jersey · Recruiting
Duke University Health System (Duke Health), Duke University Hospital
Durham, North Carolina · Recruiting
Keystone Clinical Studies LLC, dba Flourish Research
Plymouth Meeting, Pennsylvania · Withdrawn
HD Research - First Surgical Hospital
Bellaire, Texas · Recruiting
University of Texas (UT); Southwestern Medical Center
Dallas, Texas · Recruiting
NextStage Clinical Research, All American Orthopedics and Sports Medicine
Houston, Texas · Completed
Futuro Clinical Trials
McAllen, Texas · Recruiting
Flourish Research - San Antonio (Formerly Clinical Trials of Texas)
San Antonio, Texas · Recruiting
DRx Clinical Research, LLC; South Texas Bone and Joint Institute
San Antonio, Texas · Recruiting
DRx Clinical Research, LLC
St. George, Utah · Recruiting
Multi-profile Hospital for Active Treatment Hearth and Brain EAD
Pleven, Bulgaria · Recruiting
Multiprofile Hospital for Active Treatment; Sveta Sofia EOOD (MBAL Sveta Sofia),
Sofia, Bulgaria · Recruiting
University Multiprofile Hospital for Active Treatment "Prof. Dr. Stoyan Kirkovich"
Stara Zagora, Bulgaria · Withdrawn
Semmelweis University
Budapest, Hungary · Recruiting
Szegedi Tudomanyegyetem; Albert Szent-Gyorgyi Clinical Center
Szeged, Csongrad-Csanad, Hungary · Recruiting
Gyor-Moson-Sopron Varmegyei Egyetemi Oktato Korhaz
Győr, Győr-Moson-Sopron, Hungary · Recruiting
University of Debrecen
Debrecen, Hajdú-Bihar, Hungary · Recruiting
Saga University Hospital
Saga, Japan · Recruiting
Kansai Rosai Hospital
Amagasaki-shi, Hyōgo, Japan · Recruiting
Yuuai Medical Center
Tomigusuku, Okinawa, Japan · Recruiting
National Hospital Organization Osaka Minami Medical Center
Kawachi-Nagano, Osaka, Japan · Recruiting
Osaka Saiseikai Nakatsu Hospital
Kita-Ku, Osaka, Japan · Recruiting
Juntendo University Hospital
Bunkyo-ku, Tokyo, Japan · Recruiting
Liepajas regionala slimnica; SIA
Liepāja, Latvia · Recruiting
Rigas 2 slimnica, SIA
Riga, Latvia · Recruiting
Hospital of Traumatology and Orthopaedics
Riga, Latvia · Recruiting
ORTO Klinika
Riga, Latvia · Recruiting
Vidzemes slimnica
Valmiera, Latvia · Recruiting
Lietuvos sveikatos mokslu universiteto Kauno ligonine
Kaunas, Lithuania · Recruiting
Lietuvos sveikatos mokslu universiteto ligonine Kauno klinik
Kaunas, Lithuania · Recruiting
Showing 40 of 47 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.